Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Akari Therapeutics Plc
AKTX | US
2.16
USD-0.08
-3.57%
AKTX | US
About Akari Therapeutics Plc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
2.16
Open
2.23
High
2.33
Low
2.14
Akari Therapeutics Plc a clinical-stage biopharmaceutical company focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities including paroxysmal nocturnal hemoglobinuria Guillain-Barré syndrome hematopoietic stem cell transplant-associated thrombotic microangiopathy and bullous pemphigoid as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London the United Kingdom.
View LessAKTX | US
Risk
68.9
Sharpe
-0.43
Luna's Score
37/100
Recommendation
Sell
Luna says (AKTX | US)
What's Working
Low Debt to Equity (< 0.25)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
75.5%1 month
68.9%3 months
80.9%6 months
114.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.07
Debt to equity
-0.27
Debt to assets
0.20
Ent. to EBITDA
-0.06
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-18.08M
MarketCap
26.23M
MarketCap(USD)
26.23M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-1.28K
Short ratio
2.26
Short perc.
0.41
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
1.56
Range1M
1.71
Range3M
2.26
Volumes: Market Activity
Rel. volume
0.41
Price X volume
19.25K
